Establishment of a scalable microfluidic assay for characterization of population-based neutrophil chemotaxis.

Collectively, our microfluidic device shows several advantages over traditional transwell migration assays and its design is amenable to future integration into multiplexed high-throughput platforms for screening of molecules that modulate the chemotaxis of different immune cells.